Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - tablet - flucytosine 500 mg - antimycotics for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products ltd - flucytosine - tablets

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimycotics for systemic use - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

Singapore - English - HSA (Health Sciences Authority)

taiho pharma asia pacific pte. ltd. - gimeracil; oteracil potassium; tegafur - capsule - 5.8mg - gimeracil 5.8mg; oteracil potassium 19.6mg; tegafur 20mg

Singapore - English - HSA (Health Sciences Authority)

taiho pharma asia pacific pte. ltd. - gimeracil; oteracil potassium; tegafur - capsule - 7.25mg - gimeracil 7.25mg; oteracil potassium 24.5mg; tegafur 25mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - tegafur; gimeracil; oteracil potassium -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - tegafur; gimeracil; oteracil potassium -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences ltd - amphotericin b liposomal - powder for dispersion for infusion - 50mg

Australia - English - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - amphotericin b -

New Zealand - English - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - amphotericin b 50mg - powder for injection - 50 mg - active: amphotericin b 50mg excipient: cholesterol hydrochloric acid alpha-tocopherol distearoylphosphatidylglycerol phosphatidylcholines, soya, hydrogenated phosphatidylglycerols as sodium salt sodium hydroxide sodium succinate sucrose - ambisome is indicated for: · prophylaxis in liver transplant patients at risk of systemic candida, aspergillus and cryptococcus infections, and for · the treatment of systemic fungal infections caused by organisms susceptible to amphotericin b. ambisome is indicated for empirical treatment of presumed fungal infections in febrile neutropaenic patients whose fever has failed to respond to broad spectrum antibiotic treatment. ambisome is indicated for the treatment of visceral leishmaniasis. clinical studies of efficacy in visceral leishmaniasis are limited to leishmania infantum.